Celprime Pty Ltd

Status: Registered
Australian Company Number: 083080595
Australian Business Number: 72083080595
Registration date: 1998/06/23
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Celprime Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 1998-06-23 and was issued with the 083080595 ACN. Its Australian Business Number is 72083080595. Since 2006-04-02, the company is headquartered in QLD, post code 4006. The previous headquarters were located in QLD 4005 (from 2000-09-07 to 2006-04-02). Celprime Pty Ltd has been using the Celprime Pty Ltd trading name since 2000-09-07 (it should be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2006-04-02.

Details for ABN 72083080595

Type: Australian Private Company

ABN Status

Status From To
Active 2000/05/31 current

Main Name

Name From To
Celprime Pty Ltd 2000/05/31 current

Trading Names

Name From To
Celprime Pty Ltd 2000/09/07 current

Main Location

Location From To
QLD 4006 2006/04/02 current
QLD 4005 2000/09/07 2006/04/02

Advertisements

Find company

QLD 4006 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.